HAEMOPHILIA A WITH INHIBITORS
Clinical trials for HAEMOPHILIA A WITH INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A WITH INHIBITORS trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A WITH INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug Mim8 aims to prevent bleeds in hemophilia a patients
Disease control OngoingThis study tests the long-term safety and effectiveness of a new medicine called Mim8 in people with hemophilia A, including those whose bodies have developed inhibitors to standard treatment. Mim8 helps replace the missing clotting factor to prevent bleeding episodes. About 451 …
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 17, 2026 13:57 UTC
-
New daily shot could cut bleeds for hemophilia patients with inhibitors
Disease control OngoingThis study tested a new medicine called concizumab, given as a daily injection under the skin, to prevent bleeding episodes in people with hemophilia A or B who have developed inhibitors (antibodies that block standard treatment). The trial involved 134 males aged 12 and older. S…
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 04, 2026 16:30 UTC